AAAAAA
Results: 1-25/89
Authors:
CLELAND JGF
Citation: Jgf. Cleland, DIAGNOSIS OF HEART-FAILURE, HEART, 79, 1998, pp. 10-16
Authors:
CLELAND JGF
WALKER A
Citation: Jgf. Cleland et A. Walker, THERAPEUTIC OPTIONS AND COST CONSIDERATIONS IN THE TREATMENT OF ISCHEMIC-HEART-DISEASE, Cardiovascular drugs and therapy, 12, 1998, pp. 225-232
Authors:
FOLLATH F
CLELAND JGF
KLEIN W
MURPHY R
Citation: F. Follath et al., ETIOLOGY AND RESPONSE TO DRUG-TREATMENT IN HEART-FAILURE, Journal of the American College of Cardiology, 32(5), 1998, pp. 1167-1172
Authors:
COWBURN PJ
MORTON JJ
MCARTHUR JD
MACLEAN MR
DARGIE HJ
MCMURRAY JJV
CLELAND JGF
Citation: Pj. Cowburn et al., ENDOTHELIN ETB RECEPTORS ARE FUNCTIONALLY IMPORTANT IN MEDIATING VASOCONSTRICTION IN THE SYSTEMIC CIRCULATION IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION, Journal of the American College of Cardiology, 31(2), 1998, pp. 83-83
Authors:
MASSIE BM
CLELAND JGF
Citation: Bm. Massie et Jgf. Cleland, REGIONAL DIFFERENCES IN PATIENT CHARACTERISTICS IN AN INTERNATIONAL HEART-FAILURE TRIAL, Journal of the American College of Cardiology, 31(2), 1998, pp. 114-115
Authors:
COWBURN PJ
MORTON JJ
MCARTHUR JD
MACLEAN MR
DARGIE HJ
MCMURRAY JJV
CLELAND JGF
Citation: Pj. Cowburn et al., SHORT-TERM HEMODYNAMIC-EFFECTS OF BQ-123, A SELECTIVE ENDOTHELIN ETA-RECEPTOR ANTAGONIST, IN PATIENTS WITH CHRONIC HEART-FAILURE, Journal of the American College of Cardiology, 31(2), 1998, pp. 250-250
Authors:
BROWN AM
CLELAND JGF
Citation: Am. Brown et Jgf. Cleland, INFLUENCE OF CONCOMITANT DISEASE ON PATTERNS OF HOSPITALIZATION IN PATIENTS WITH HEART-FAILURE DISCHARGED FROM SCOTTISH HOSPITALS IN 1995, European heart journal, 19(7), 1998, pp. 1063-1069
Authors:
MCMURRAY JV
MCDONAGH TA
DAVIE AP
CLELAND JGF
FRANCIS CM
MORRISON C
Citation: Jv. Mcmurray et al., SHOULD WE SCREEN FOR ASYMPTOMATIC LEFT-VENTRICULAR DYSFUNCTION TO PREVENT HEART-FAILURE, European heart journal, 19(6), 1998, pp. 842-846
Authors:
COWBURN PJ
CLELAND JGF
COATS AJS
KOMAJDA M
Citation: Pj. Cowburn et al., RISK STRATIFICATION IN CHRONIC HEART-FAILURE, European heart journal, 19(5), 1998, pp. 696-710
Authors:
CLELAND JGF
CLARK AL
Citation: Jgf. Cleland et Al. Clark, LEPTIN AND CARDIAC CACHEXIA - MARKER OR MEDIATOR, European heart journal, 19(10), 1998, pp. 1421-1422
Authors:
CAMPBELL RWF
WALLENTIN L
VERHEUGT FWA
TURPIE AGG
MASERI A
KLEIN W
CLELAND JGF
BODE C
BECKER R
ANDERSON J
BERTRAND ME
CONTI CR
Citation: Rwf. Campbell et al., MANAGEMENT STRATEGIES FOR A BETTER OUTCOME IN UNSTABLE CORONARY-ARTERY DISEASE, Clinical cardiology, 21(5), 1998, pp. 314-322
Authors:
CLELAND JGF
MCGOWAN J
COWBURN PJ
Citation: Jgf. Cleland et al., BETA-BLOCKERS FOR CHRONIC HEART-FAILURE - FROM PREJUDICE TO ENLIGHTENMENT, Journal of cardiovascular pharmacology, 32, 1998, pp. 52-60
Authors:
COWBURN PJ
CLELAND JGF
MCARTHUR JD
MACLEAN MR
MCMURRAY JJV
DARGIE HJ
Citation: Pj. Cowburn et al., SHORT-TERM HEMODYNAMIC-EFFECTS OF BQ-123, A SELECTIVE ENDOTHELIN ETA-RECEPTOR ANTAGONIST, IN CHRONIC HEART-FAILURE, Lancet, 352(9123), 1998, pp. 201-202
Authors:
CLELAND JGF
Citation: Jgf. Cleland, HEART-FAILURE - A MEDICAL HYDRA, Lancet, 352, 1998, pp. 1-2
Authors:
CLELAND JGF
SWEDBERG K
POOLEWILSON PA
Citation: Jgf. Cleland et al., SUCCESSES AND FAILURES OF CURRENT TREATMENT OF HEART-FAILURE, Lancet, 352, 1998, pp. 19-28
Authors:
CLELAND JGF
SWEDBERG K
Citation: Jgf. Cleland et K. Swedberg, LACK OF EFFICACY OF NEUTRAL ENDOPEPTIDASE INHIBITOR ECADOTRIL IN HEART-FAILURE, Lancet, 351(9116), 1998, pp. 1657-1658
Authors:
CLELAND JGF
FORD I
Citation: Jgf. Cleland et I. Ford, INTERPRETATION OF THROMBOSIS PREVENTION TRIAL, Lancet, 351(9110), 1998, pp. 1205-1206
Authors:
CLELAND JGF
Citation: Jgf. Cleland, ARE SYMPTOMS THE MOST IMPORTANT TARGET FOR THERAPY IN CHRONIC HEART-FAILURE, Progress in cardiovascular diseases, 41(1), 1998, pp. 59-64
Authors:
MASSIE BM
ARMSTRONG PW
CLELAND JGF
HOROWTIZ JJD
PACKER M
POOLEWILSON PA
RYDEN L
Citation: Bm. Massie et al., EXCELLENT TOLERABILITY OF HIGH-DOSES OF LISINOPRIL IN THE ATLAS TRIAL, Circulation, 98(17), 1998, pp. 416-416
Authors:
CLELAND JGF
MASSIE BM
PACKER M
ARMSTRONG PW
HOROWITZ JD
RYDEN L
POOLEWILSON PA
Citation: Jgf. Cleland et al., HEALTH ECONOMIC-BENEFITS OF TREATING PATIENTS WITH HEART-FAILURE WITHHIGH-DOSE LISINOPRIL VERSUS LOW-DOSE - THE ATLAS STUDY, Circulation, 98(17), 1998, pp. 698-698
Authors:
COWBURN PJ
CLELAND JGF
MCDONAGH TA
MCARTHUR JD
MACLEAN MR
DARGIE HJ
Citation: Pj. Cowburn et al., ADVERSE HEMODYNAMIC-EFFECTS OF A SELECTIVE ENDOTHELIN ETB RECEPTOR ANTAGONIST IN PATIENTS WITH CHRONIC HEART-FAILURE - REVERSAL WITH A SELECTIVE ENDOTHELIN ETA-RECEPTOR ANTAGONIST, Circulation, 98(17), 1998, pp. 3773-3773
Authors:
COWBURN PJ
CLELAND JGF
MCARTHUR JD
MACLEAN MR
DARGIE HJ
MCMURRAY JJV
MORTON JJ
Citation: Pj. Cowburn et al., ENDOTHELIN-1 HAS HEMODYNAMIC-EFFECTS AT PATHOPHYSIOLOGICAL CONCENTRATIONS IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION, Cardiovascular Research, 39(3), 1998, pp. 563-570
COMBINATION-DRUG THERAPY IN CHRONIC HEART-FAILURE - IS TREATMENT PARTOF THE PROBLEM IN HEART-FAILURE
Authors:
CLELAND JGF
Citation: Jgf. Cleland, COMBINATION-DRUG THERAPY IN CHRONIC HEART-FAILURE - IS TREATMENT PARTOF THE PROBLEM IN HEART-FAILURE, Cardiovascular drugs and therapy, 11, 1997, pp. 297-303
Authors:
CLELAND JGF
Citation: Jgf. Cleland, CHRONIC HEMODYNAMIC-EFFECTS OF CANDOXATRIL - A MULTICENTER DOSE-RANGING STUDY, Journal of the American College of Cardiology, 29(2), 1997, pp. 7272-7272
Authors:
COWBURN PJ
MCARTHUR JD
MCLEAN MR
MCMURRAY JJV
DARGIE HJ
CLELAND JGF
Citation: Pj. Cowburn et al., CENTRAL HEMODYNAMIC-EFFECTS OF ENDOTHELIN-1 IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION, Journal of the American College of Cardiology, 29(2), 1997, pp. 99672-99672